eHealth reported strong Q4 2024 results, exceeding expectations with a 27% increase in total revenue to $315.2 million and an 87% increase in GAAP net income to $97.5 million. The company's performance was driven by a 42% growth in Medicare Advantage submissions and a 16% expansion in Medicare unit margin. eHealth ended the year with a record-high commissions receivable balance of $1.0 billion.
Total Medicare submissions grew by 38% in Q4 2024, with Medicare Advantage submissions increasing by 42% year-over-year.
Total Medicare approved members increased by 33% year-over-year, driven by a 39% increase in MA approved members.
Total revenue increased by 27% to $315.2 million, driven primarily by Medicare segment growth.
GAAP net income increased by 87% to $97.5 million.
eHealth provided guidance for the full year ending December 31, 2025, with total revenue expected to be in the range of $510.0 million to $550.0 million, GAAP net income (loss) expected to be in the range of $(10.0) million to $15.0 million, adjusted EBITDA expected to be in the range of $35.0 million to $60.0 million, and operating cash flow expected to be in the range of $(25.0) million to $10.0 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance